BLISS GVS PHARMA share price has zoomed 6% and is presently trading at Rs 135.7.
Meanwhile, the BSE HEALTHCARE index is at 44,560.2 (down 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 2.2%) and GSK Pharma (up 2.1%).
Torrent Pharma (down 1.7%) and Jubilant Pharmova (down 1.3%) are among the top losers today.
Over the last one year, BLISS GVS PHARMA has moved up from Rs 89.3 to Rs 135.7, registering a gain of Rs 46.4 (up 52.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,166.2 to 44,560.2, registering a gain of 58.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 198.8%), Glenmark Pharma (up 122.4%) and SUVEN PHARMACEUTICALS (up 114.6%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 81,199.3 (down 0.4%).
The top losers among the BSE Sensex today are M&M (down 2.6%) and Maruti Suzuki (down 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.
In the meantime, NSE Nifty is at 24,821.7 (down 0.6%). Bajaj Auto and Hero Motocorp are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,166.9 to 81,199.3, registering a gain of 15,032.4 points (up 22.7%).
BLISS GVS PHARMA net profit grew 53.8% YoY to Rs 221 million for the quarter ended June 2024, compared to a profit of Rs 144 million a year ago. Net sales rose 15.1% to Rs 1,836 million during the period as against Rs 1,595 million in April-June 2023.
For the year ended March 2024, BLISS GVS PHARMA reported 6.3% increase in net profit to Rs 816 million compared to net profit of Rs 767 million during FY23. Revenue of the company grew 2.5% to Rs 7,702 million during FY24.
The current Price to earnings ratio of BLISS GVS PHARMA, based on rolling 12 month earnings, stands at 16.0.
Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!